DCM
EDIT icon

Driehaus Capital Management’s Editas Medicine EDIT Stock Holding History

Driehaus Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-125,684
Closed -$2.81M – 567
2017
Q1 		$2.81M Buy
125,684
+79,104
+170% +$1.64M 0.1% 219
2016
Q4 		$756K Buy
+46,580
New +$707K 0.03% 379

Other funds holding EDIT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
PVMCV
Polaris Venture Management Co VI Boston, Massachusetts $43.1M AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Driehaus Capital Management's EDIT Position: Q2 2017 in Review

Driehaus Capital Management sold out of Editas Medicine (EDIT) in Q2 2017, closing a stake of 125,684 shares — an estimated $2.81M sold.

Driehaus Capital Management first reported a position in EDIT in Q4 2016 and held it in 2 quarters. The position peaked at $2.81M in Q1 2017. 110 funds tracked by Wall St. Rank hold EDIT as of Q2 2017.

  • Driehaus Capital Management reported no remaining Editas Medicine position as of Q2 2017 after selling out during the quarter.
  • Driehaus Capital Management sold 125,684 Editas Medicine shares in Q2 2017, an estimated $2.81M.
  • Driehaus Capital Management first reported a position in Editas Medicine in Q4 2016 and held it in 2 quarters.
  • Driehaus Capital Management's Editas Medicine position peaked at $2.81M in Q1 2017.
  • 110 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2017.

Based on Driehaus Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.